0001572426-15-000048.txt : 20150520
0001572426-15-000048.hdr.sgml : 20150520
20150520182946
ACCESSION NUMBER: 0001572426-15-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150518
FILED AS OF DATE: 20150520
DATE AS OF CHANGE: 20150520
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAYNE JOHN BERNARD
CENTRAL INDEX KEY: 0001582392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 15880820
MAIL ADDRESS:
STREET 1: 9900 NE 114TH CIRCLE
CITY: VANCOUVER
STATE: WA
ZIP: 98662
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-05-18
0001618561
Nexvet Biopharma plc
NVET
0001582392
PAYNE JOHN BERNARD
C/O NEXVET BIOPHARMA PLC
NIBRT; FOSTERS AVENUE, MOUNT MERRION
BLACKROCK
L2
IRELAND
1
0
0
0
Ordinary Shares
2015-05-18
4
M
0
900
.125
A
2700
D
Ordinary Shares
6195
I
John Payne <John B. Payne Living A/C>
Restricted Stock Units
.125
2015-05-18
4
M
0
900
0
D
2015-03-31
2019-07-01
Ordinary Shares
900
900
D
The reporting person has sole voting and dispositive power with respect to these reported securities.
50% of the Restricted Share Units vested and became convertible on 3/31/15, and the remaining 50% shall vest and become convertible on 6/30/15, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.
/s/ John Payne by Geraldine T. Farrell, Attorney-in-Fact
2015-05-20